Lampela P, Tolppanen AM, Kaarniranta K, Hokkinen K, Hartikainen S. Incidence of cataract surgeries in relation to diagnosis of Parkinson’s Disease. Arch Gerontol Geriatr. 2023;104:104842.

Article  PubMed  Google Scholar 

Hiller BM, Marmion DJ, Thompson CA, Elliott NA, Federoff H, Brundin P, et al. Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s Disease. NPJ Regen Med. 2022;7(1):24.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Reeve A, Simcox E, Turnbull D. Ageing and Parkinson’s Disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14(100):19–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sharma S, Awasthi A, Singh S. Altered gut microbiota and intestinal permeability in Parkinson’s Disease: pathological highlight to management. Neurosci Lett. 2019;712:134516.

Article  PubMed  CAS  Google Scholar 

Su A, Gandhy R, Barlow C, Triadafilopoulos G. A practical review of gastrointestinal manifestations in Parkinson’s Disease. Parkinsonism Relat Disord. 2017;39:17–26.

Article  PubMed  Google Scholar 

Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, et al. Association of Parkinson’s Disease with microbes and microbiological therapy. Front Cell Infect Microbiol. 2021;11:619354.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bisaglia M. Mediterranean diet and Parkinson’s Disease. Int J Mol Sci. 2022;24(1):42.

Article  PubMed  PubMed Central  Google Scholar 

Fan HX, Sheng S, Zhang F. New hope for Parkinson’s Disease treatment: targeting gut microbiota. CNS Neurosci Ther. 2022;28(11):1675–88.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ivan IF, Irincu VL, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson’s Disease (review). Exp Ther Med. 2021;22(4):1083.

Article  PubMed  PubMed Central  Google Scholar 

Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s Disease. Mov Disord. 2018;33(8):1248–66.

Article  PubMed  CAS  Google Scholar 

Deng R, Zheng H, Cai H, Li M, Shi Y, Ding S. Effects of helicobacter pylori on Tumor microenvironment and immunotherapy responses. Front Immunol. 2022;13:923477.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the role of lipopolysaccharide variation in innate immune evasion. Front Immunol. 2022;13:868225.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, et al. Helicobacter pylori Infection and extragastric diseases-A focus on the central nervous system. Cells. 2021;10(9):2191.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kountouras J, Zavos C, Polyzos SA, Deretzi G, Vardaka E, Giartza-Taxidou E, et al. Helicobacter pylori Infection and Parkinson’s Disease: apoptosis as an underlying common contributor. Eur J Neurol. 2012;19(6):e56.

Article  PubMed  CAS  Google Scholar 

Gorlé N, Bauwens E, Haesebrouck F, Smet A, Vandenbroucke RE. Helicobacter and the potential role in neurological disorders: there is more than Helicobacter pylori. Front Immunol. 2020;11:584165.

Article  PubMed  Google Scholar 

Noto JM, Peek RM Jr. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to Stomach cancer. PLoS Pathog. 2017;13(10):e1006573.

Article  PubMed  PubMed Central  Google Scholar 

Shen S, Zhang C, Xu YM, Shi CH. The role of pathogens and anti-infective agents in Parkinson’s Disease, from etiology to therapeutic implications. J Parkinsons Dis. 2022;12(1):27–44.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lubomski M, Davis RL, Sue CM. Gastrointestinal dysfunction in Parkinson’s Disease. J Neurol. 2020;267(5):1377–88.

Article  PubMed  CAS  Google Scholar 

Li Z, Liang H, Hu Y, Lu L, Zheng C, Fan Y, et al. Gut bacterial profiles in Parkinson’s Disease: a systematic review. CNS Neurosci Ther. 2023;29(1):140–57.

Article  PubMed  CAS  Google Scholar 

Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and Disease. Front Physiol. 2011;2:94.

Article  PubMed  PubMed Central  Google Scholar 

Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson’s Disease. World J Gastroenterol. 2015;21(37):10609–20.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Travagli RA, Browning KN, Camilleri M. Parkinson Disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2020;17(11):673–85.

Article  PubMed  CAS  Google Scholar 

Sun X, Xue L, Wang Z, Xie A. Update to the treatment of Parkinson’s Disease based on the gut-brain axis mechanism. Front Neurosci. 2022;16:878239.

Article  PubMed  PubMed Central  Google Scholar 

Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s Disease. Neurobiol Aging. 2003;24(2):197–211.

Article  PubMed  Google Scholar 

Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Björklund T, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128(6):805–20.

Article  PubMed  Google Scholar 

Chen QQ, Haikal C, Li W, Li JY. Gut inflammation in association with pathogenesis of Parkinson’s Disease. Front Mol Neurosci. 2019;12:218.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shannon KM. Infections and changes in commensal bacteria and the pathogenesis of Parkinson’s Disease. J Parkinsons Dis. 2022;12(s1):45–S51.

Article  Google Scholar 

Shamsdin SA, Khazraei H, Rahimi Jaberi A, Zamani M, Rafiee Monjezi M. Evaluation of inflammatory cytokine and anti Helicobacter pylori antibodies in the pathogenesis of Parkinson’s Disease. Middle East J Dig Dis. 2022;14(1):96–102.

Article  PubMed  PubMed Central  Google Scholar 

Dobbs RJ, Charlett A, Dobbs SM, Weller C, MA AI, Iguodala O, et al. Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study. Gut Pathog. 2012;4(1):12.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rahne KE, Tagesson C, Nyholm D. Motor fluctuations and Helicobacter pylori in Parkinson’s Disease. J Neurol. 2013;260(12):2974–80.

Article  PubMed  Google Scholar 

Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, et al. Eradication of Helicobacter pylori Infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson’s Disease. PLoS ONE. 2014;9(11):e112330.

Article  PubMed  PubMed Central  Google Scholar 

Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM, et al. Helicobacter pylori Infection is associated with worse severity of Parkinson’s Disease. Parkinsonism Relat Disord. 2015;21(3):221–5.

Article  PubMed  Google Scholar 

Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, et al. Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary Progressive multiple sclerosis. Sci Rep. 2017;7(1):7929.

Article  PubMed  PubMed Central  Google Scholar 

Liu H, Su W, Li S, Du W, Ma X, Jin Y, et al. Eradication of Helicobacter pylori Infection might improve clinical status of patients with Parkinson’s Disease, especially on bradykinesia. Clin Neurol Neurosurg. 2017;160:101–4.

Article  PubMed  Google Scholar 

Mridula KR, Borgohain R, Chandrasekhar Reddy V, Bandaru V, Suryaprabha T. Association of Helicobacter pylori with Parkinson’s Disease. J Clin Neurol. 2017;13(2):181–6.

Article  PubMed  PubMed Central  Google Scholar 

Roshan T, Bijani A, Hosseini SR, Bagherzade M, Saadat P, Zamani M. The association between Helicobacter pylori Infection and Parkinson’s Disease: a case-control study. J Clin Diagn Res. 2018;12:OC05–8.

CAS  Google Scholar